Market Research

Market Research for Life Sciences

Custom primary market research for pharma, biotech, and medtech, answering your hardest commercial questions across the brand lifecycle.

Big Decisions, Incomplete Answers

Every brand decision rests on what you know about your market and your customers. When research is slow, generic, or hard to act on, the gaps show up in your choices. You size the opportunity wrong. You position against the wrong competitor. You launch into a market that already moved. In life sciences, those misses are expensive and hard to reverse. You need answers that are clear, fast, and built for the question in front of you.

Answers Built for Your Question

We design each study around your business question. The findings point to a clear next step.

Size the Real Opportunity

Understand the factors shaping expected use and identify the levers to increase adoption.

Test an Asset Early

Test target product profiles (TPP) with key stakeholders to identify meaningful attributes, trade-offs, and evidence requirements before development decisions are locked.

Map the Patient Journey

Develop a real-world view of the patient journey, from symptom onset through diagnosis and long-term management, to uncover barriers and brand opportunities.

Segment and Target

Pinpoint the preferences and behaviors that drive decision making and enable customized engagement and targeting. Focus resources on the HCPs (Health Care Providers) most likely to influence the market.

How We Help

Full method range: From in-depth interviews and AI-enabled insight generation to advanced quantitative studies with physicians, patients, and payers.
Advanced modeling: Patient simulation, discrete choice, and predictive modeling that explain expected outcomes and their drivers.
Whole-lifecycle coverage: Demand assessment, segmentation, pricing, patient journey research, and performance tracking across pre-launch and post-launch stages.
Connected expertise: Direct links to Trinity’s Centers of Excellence, connecting research to the relevant clinical, commercial, access, or analytics expertise.
Objective guidance: Evidence-based recommendations informed by deep clinical and commercial expertise.